168 related articles for article (PubMed ID: 37468859)
1. RFID trial: localization of non-palpable breast lesions using radiofrequency identification tags or wire.
Veyssiere H; Dressaire M; Pete R; Pinard C; Molnar I; Abrial C; Ginzac A; Durando X; Tekath M
BMC Cancer; 2023 Jul; 23(1):679. PubMed ID: 37468859
[TBL] [Abstract][Full Text] [Related]
2. A multicenter prospective cohort study to evaluate feasibility of radio-frequency identification surgical guidance for nonpalpable breast lesions: design and rationale of the RFID Localizer 1 Trial.
den Dekker BM; Christenhusz A; van Dalen T; Jongen LM; van der Schaaf MC; Dassen AE; Pijnappel RM
BMC Cancer; 2022 Mar; 22(1):305. PubMed ID: 35317766
[TBL] [Abstract][Full Text] [Related]
3. First Reported Use of the Faxitron LOCalizer™ Radiofrequency Identification (RFID) System in Europe - A Feasibility Trial, Surgical Guide and Review for Non-palpable Breast Lesions.
Malter W; Holtschmidt J; Thangarajah F; Mallmann P; Krug B; Warm M; Eichler C
In Vivo; 2019; 33(5):1559-1564. PubMed ID: 31471405
[TBL] [Abstract][Full Text] [Related]
4. A comparison of two non-radioactive alternatives to wire for the localization of non-palpable breast cancers.
Lee MK; Sanaiha Y; Kusske AM; Thompson CK; Attai DJ; Baker JL; Fischer CP; DiNome ML
Breast Cancer Res Treat; 2020 Jul; 182(2):299-303. PubMed ID: 32451679
[TBL] [Abstract][Full Text] [Related]
5. Wireless Breast Localization Using Radio-frequency Identification Tags: The First Reported European Experience in Breast Cancer.
Wazir U; Tayeh S; Perry N; Michell M; Malhotra A; Mokbel K
In Vivo; 2020; 34(1):233-238. PubMed ID: 31882483
[TBL] [Abstract][Full Text] [Related]
6. The LOCalizer Radiofrequency Identification System: An Effective New Technology for Localizing Non-Palpable Breast Lesions for Surgery.
Cullinane CM; Byrne J; Akmenkalne L; O' Leary DP; Connors AM; Corrigan MA; Redmond HP; Kelly L; O' Sullivan MJ
Surg Innov; 2021 Aug; 28(4):473-478. PubMed ID: 33085567
[No Abstract] [Full Text] [Related]
7. Radio-frequency identification (RFID) tag localisation of non-palpable breast lesions a single centre experience.
Almalki H; Rankin AC; Juette A; Youssef MG
Breast; 2023 Jun; 69():417-421. PubMed ID: 37141675
[TBL] [Abstract][Full Text] [Related]
8. A prospective clinical study to evaluate the safety and performance of wireless localization of nonpalpable breast lesions using radiofrequency identification technology.
Dauphine C; Reicher JJ; Reicher MA; Gondusky C; Khalkhali I; Kim M
AJR Am J Roentgenol; 2015 Jun; 204(6):W720-3. PubMed ID: 26001262
[TBL] [Abstract][Full Text] [Related]
9. Radiofrequency identification tag localization is comparable to wire localization for non-palpable breast lesions.
McGugin C; Spivey T; Coopey S; Smith B; Kelly B; Gadd M; Hughes K; Dontchos B; Specht M
Breast Cancer Res Treat; 2019 Oct; 177(3):735-739. PubMed ID: 31302856
[TBL] [Abstract][Full Text] [Related]
10. Retrospective Review of Preoperative Radiofrequency Tag Localization of Breast Lesions in 848 Patients.
Lamb LR; Gilman L; Specht M; D'Alessandro HA; Miles RC; Lehman CD
AJR Am J Roentgenol; 2021 Sep; 217(3):605-612. PubMed ID: 33084384
[No Abstract] [Full Text] [Related]
11. Evaluation of a Wireless Localization System for Nonpalpable Breast Lesions - Feasibility and Cost-effectiveness in Everyday Clinical Routine.
Heindl F; Schulz-Wendtland R; Jud S; Erber R; Hack CC; Preuss C; Behrens A; Pöschke P; Emons J
In Vivo; 2022; 36(5):2342-2349. PubMed ID: 36099117
[TBL] [Abstract][Full Text] [Related]
12. Radiofrequency localization of nonpalpable breast cancer in a multicentre prospective cohort study: feasibility, clinical acceptability, and safety.
Christenhusz A; den Dekker BM; van Dalen T; Jongen L; van der Schaaf MC; Alic L; Ten Haken B; Pijnappel RM; Dassen AE
Breast Cancer Res Treat; 2023 Aug; 201(1):67-75. PubMed ID: 37322358
[TBL] [Abstract][Full Text] [Related]
13. First Reported Use of Radiofrequency Identification (RFID) Technique for Targeted Excision of Suspicious Axillary Lymph Nodes in Early Stage Breast Cancer - Evaluation of Feasibility and Review of Current Recommendations.
Malter W; Eichler C; Hanstein B; Mallmann P; Holtschmidt J
In Vivo; 2020; 34(3):1207-1213. PubMed ID: 32354911
[TBL] [Abstract][Full Text] [Related]
14. Combined LOCalizer™ and Intraoperative Ultrasound Localization: First Experience in Localization of Non-palpable Breast Cancer.
Parisi S; Ruggiero R; Gualtieri G; Volpe ML; Rinaldi S; Nesta G; Bogdanovich L; Lucido FS; Tolone S; Parmeggiani D; Gambardella C; Docimo L
In Vivo; 2021; 35(3):1669-1676. PubMed ID: 33910851
[TBL] [Abstract][Full Text] [Related]
15. Use of Hologic LOCalizer radiofrequency identification (RFID) tags to localise impalpable breast lesions and axillary nodes: experience of the first 150 cases in a UK breast unit.
Lowes S; Bell A; Milligan R; Amonkar S; Leaver A
Clin Radiol; 2020 Dec; 75(12):942-949. PubMed ID: 32919756
[TBL] [Abstract][Full Text] [Related]
16. Localization techniques for guided surgical excision of non-palpable breast lesions.
Chan BK; Wiseberg-Firtell JA; Jois RH; Jensen K; Audisio RA
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD009206. PubMed ID: 26718728
[TBL] [Abstract][Full Text] [Related]
17. The Evolving Role of Radiofrequency Guided Localisation in Breast Surgery: A Systematic Review.
Tayeh S; Wazir U; Mokbel K
Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638480
[TBL] [Abstract][Full Text] [Related]
18. Radio-Frequency Identifier Devices (RFIDs): Our Experience With Wireless Localisation in Non-palpable Breast Masses at a UK Tertiary Breast Imaging Unit.
Singh C; Juette A
Cureus; 2022 Feb; 14(2):e22402. PubMed ID: 35345700
[TBL] [Abstract][Full Text] [Related]
19. The Use of Magnetic Seeds and Radiofrequency Identifier Tags in Breast Surgery for Non-palpable Lesions.
Tayeh S; Gera R; Perry N; Michell M; Malhotra A; Mokbel K
Anticancer Res; 2020 Jan; 40(1):315-321. PubMed ID: 31892582
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of the Radiofrequency Identification Technique in Breast Cancer Patients: A Single Institution Retrospective Study.
Kassem M; Kamr A; Wright CB; Sobolewski AP
Eur J Breast Health; 2024 Jan; 20(1):52-56. PubMed ID: 38187107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
